What
is the most scary, is reading this sentence about the therapies that
are suppose to slow the progression of the disease: They don’t know why
[it] works, but….” With therapies like Copaxone and Tecfidera, there are
many instances of those words spilling out into articles and after
research, it is found to be true. They don’t know why they work.
After
all these years and the millions of dollars that has been spent on
studying this disease, scientists have found themselves being able to
only pick a part of the disease, taking the gestalt of it (the whole)
and micromanaging the various different areas. For instance, some work
on the symptoms and how to help control them i.e. balancing issues and
Ampyra or spasticity and baclofen and some work on trying to control the
disease itself.
Those include
shot therapies like Rebif or pill therapies like Tecfidera. This is
where the scary part comes into play because even though studies have
proven they do work for the vast majority of MS patients, the
researchers don’t know why.
They
think it is because it will inhibit the immune cells or it could also
possibly be because they also have anti-oxidants to protect the brain
and the spinal cord but they don’t know exactly why these incredibly
powerful and exceedingly expensive medications work.
Story Source: The above story is based on materials provided by EXAMINER
Note: Materials may be edited for content and length
